KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Return on Assets (2016 - 2026)

Teva Pharmaceutical Industries (TEVA) has disclosed Return on Assets for 18 consecutive years, with 0.0% as the latest value for Q1 2026.

  • Quarterly Return on Assets changed 0.0% to 0.0% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.0% through Mar 2026, changed 0.0% year-over-year, with the annual reading at 0.0% for FY2025, 0.0% changed from the prior year.
  • Return on Assets for Q1 2026 was 0.0% at Teva Pharmaceutical Industries, up from 0.0% in the prior quarter.
  • The five-year high for Return on Assets was 0.0% in Q1 2026, with the low at 0.0% in Q4 2022.
  • Average Return on Assets over 5 years is 0.0%, with a median of 0.0% recorded in 2023.
  • The widest YoY moves for Return on Assets: up 0bps in 2022, down 0bps in 2022.
  • Teva Pharmaceutical Industries' Return on Assets stood at 0.0% in 2022, then skyrocketed by 75bps to 0.0% in 2023, then tumbled by -75bps to 0.0% in 2024, then skyrocketed by 238bps to 0.0% in 2025, then increased by 10bps to 0.0% in 2026.
  • Per Business Quant, the three most recent readings for TEVA's Return on Assets are 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025).